Pricing Log in Create free account

Kodiak Sciences Inc. (KOD) vs PTC Therapeutics, Inc. (PTCT)

Kodiak Sciences Inc. and PTC Therapeutics, Inc. are both Biotechnology companies. Kodiak Sciences Inc. and PTC Therapeutics, Inc. are of similar size ($5.5B and $5.1B). Kodiak Sciences Inc. has the higher net margin (0.00% vs −3.80%) and the lower return on invested capital (0.00% vs 15.2%). Across the 13 metrics below, PTC Therapeutics, Inc. leads on 10 and Kodiak Sciences Inc. on 3.

Valuation

Metric KOD PTCT Biotechnology median
P/E n/m n/m 8.50
P/S n/m 4.87 9.71
P/B 87.90 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 34.41 0.64
EV/Sales n/m 5.55 9.21
Earnings yield (4.89%) (0.83%) (33.15%)
Free cash flow yield (2.98%) (6.11%) (25.50%)

Profitability

Metric KOD PTCT Biotechnology median
Gross margin 0.00% 92.99% 65.16%
Operating margin 0.00% 12.45% 0.00%
Net margin 0.00% (3.80%) 0.00%
Free cash flow margin 0.00% (29.76%) 0.00%
Return on equity (368.37%) 20.64% (56.36%)
Return on assets (94.25%) (1.30%) (48.04%)
Return on invested capital 0.00% 15.16% 0.00%

Growth

Metric KOD PTCT Biotechnology median
Revenue growth (TTM) — (42.84%) 6.02%
EPS growth (last fiscal year) (28.96%) 264.48% 30.26%
Revenue growth, 5-year CAGR — 35.37% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric KOD PTCT Biotechnology median
Debt to equity 0.00 (17.61) 0.00
Current ratio 2.49 3.39 4.72
Net debt to EBITDA 1.01 0.73 0.96

Dividend

Metric KOD PTCT Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric KOD PTCT Biotechnology median
Market cap 5.54b 5.09b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack